Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Image Processing, Computer-Assisted | 34 | 2020 | 242 | 10.510 |
Why?
|
Image Interpretation, Computer-Assisted | 25 | 2023 | 113 | 6.640 |
Why?
|
Algorithms | 34 | 2022 | 462 | 5.120 |
Why?
|
Lymphoma, Follicular | 13 | 2018 | 19 | 4.420 |
Why?
|
Pattern Recognition, Automated | 14 | 2015 | 34 | 4.210 |
Why?
|
Diagnosis, Computer-Assisted | 11 | 2019 | 46 | 3.950 |
Why?
|
Microscopy | 9 | 2019 | 27 | 3.320 |
Why?
|
Ki-67 Antigen | 5 | 2023 | 29 | 2.670 |
Why?
|
Artificial Intelligence | 11 | 2023 | 49 | 2.510 |
Why?
|
Breast Neoplasms | 9 | 2023 | 666 | 1.830 |
Why?
|
Cell Nucleus | 4 | 2018 | 105 | 1.790 |
Why?
|
User-Computer Interface | 8 | 2017 | 34 | 1.740 |
Why?
|
Immunohistochemistry | 7 | 2019 | 519 | 1.710 |
Why?
|
Reproducibility of Results | 20 | 2020 | 726 | 1.690 |
Why?
|
Humans | 76 | 2024 | 29093 | 1.690 |
Why?
|
Neuroblastoma | 7 | 2017 | 32 | 1.590 |
Why?
|
Pathology | 3 | 2019 | 20 | 1.410 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 208 | 1.410 |
Why?
|
Prognosis | 10 | 2024 | 1362 | 1.270 |
Why?
|
Information Storage and Retrieval | 6 | 2020 | 24 | 1.270 |
Why?
|
Software | 7 | 2017 | 109 | 1.240 |
Why?
|
Neuroendocrine Tumors | 2 | 2018 | 20 | 1.140 |
Why?
|
Histocytochemistry | 4 | 2016 | 30 | 1.130 |
Why?
|
Tympanic Membrane | 3 | 2020 | 6 | 1.100 |
Why?
|
Brain Neoplasms | 4 | 2017 | 587 | 1.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2022 | 1218 | 1.030 |
Why?
|
Staining and Labeling | 5 | 2020 | 56 | 1.010 |
Why?
|
Diagnostic Imaging | 4 | 2017 | 88 | 1.000 |
Why?
|
Neoplasms | 3 | 2023 | 610 | 0.990 |
Why?
|
Neoplasm Staging | 2 | 2019 | 436 | 0.960 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 15 | 0.960 |
Why?
|
Sensitivity and Specificity | 13 | 2018 | 532 | 0.830 |
Why?
|
Lung | 3 | 2015 | 233 | 0.830 |
Why?
|
Phantoms, Imaging | 2 | 2018 | 56 | 0.800 |
Why?
|
Pathology, Clinical | 3 | 2017 | 14 | 0.800 |
Why?
|
Cystic Fibrosis | 2 | 2013 | 23 | 0.780 |
Why?
|
Osteoarthritis, Knee | 2 | 2012 | 80 | 0.780 |
Why?
|
Polypyrimidine Tract-Binding Protein | 2 | 2017 | 2 | 0.760 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2017 | 4 | 0.750 |
Why?
|
Pathology, Surgical | 1 | 2019 | 3 | 0.730 |
Why?
|
Biopsy | 3 | 2018 | 241 | 0.680 |
Why?
|
Rosacea | 1 | 2019 | 46 | 0.670 |
Why?
|
Female | 25 | 2023 | 18164 | 0.670 |
Why?
|
Osteoarthritis | 2 | 2010 | 74 | 0.670 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2013 | 40 | 0.660 |
Why?
|
T-Lymphocytes | 2 | 2017 | 114 | 0.650 |
Why?
|
Tomography, X-Ray Computed | 4 | 2022 | 871 | 0.650 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 44 | 0.640 |
Why?
|
Skin Diseases | 1 | 2019 | 138 | 0.630 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2020 | 179 | 0.630 |
Why?
|
Image Enhancement | 8 | 2014 | 70 | 0.620 |
Why?
|
Observer Variation | 5 | 2020 | 96 | 0.610 |
Why?
|
Gliosis | 1 | 2017 | 4 | 0.600 |
Why?
|
Histology | 3 | 2016 | 5 | 0.590 |
Why?
|
Antibodies | 1 | 2017 | 53 | 0.590 |
Why?
|
Imaging, Three-Dimensional | 2 | 2011 | 130 | 0.580 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 131 | 0.580 |
Why?
|
Abdomen | 1 | 2016 | 42 | 0.560 |
Why?
|
Liver | 2 | 2016 | 464 | 0.560 |
Why?
|
Radiology Information Systems | 4 | 2007 | 13 | 0.550 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 75 | 0.540 |
Why?
|
Fatty Liver | 1 | 2016 | 66 | 0.530 |
Why?
|
Mycobacterium tuberculosis | 2 | 2015 | 7 | 0.520 |
Why?
|
Lymphoma | 2 | 2018 | 36 | 0.490 |
Why?
|
Granuloma | 1 | 2013 | 13 | 0.480 |
Why?
|
Child | 6 | 2023 | 2219 | 0.480 |
Why?
|
Glioblastoma | 1 | 2015 | 143 | 0.480 |
Why?
|
Brain | 3 | 2022 | 930 | 0.480 |
Why?
|
Stromal Cells | 3 | 2009 | 70 | 0.470 |
Why?
|
Lymphocytes | 1 | 2013 | 53 | 0.470 |
Why?
|
Knowledge Bases | 1 | 2012 | 1 | 0.440 |
Why?
|
Data Mining | 1 | 2012 | 7 | 0.440 |
Why?
|
Femur | 2 | 2011 | 67 | 0.430 |
Why?
|
Wounds and Injuries | 1 | 2015 | 250 | 0.420 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 441 | 0.400 |
Why?
|
Muscle Fibers, Slow-Twitch | 1 | 2011 | 20 | 0.400 |
Why?
|
Male | 13 | 2020 | 17807 | 0.390 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 2011 | 29 | 0.390 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2011 | 28 | 0.390 |
Why?
|
Tibia | 1 | 2011 | 56 | 0.390 |
Why?
|
Quadriceps Muscle | 1 | 2010 | 31 | 0.360 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 80 | 0.360 |
Why?
|
Otoscopy | 2 | 2020 | 3 | 0.350 |
Why?
|
Ear Diseases | 2 | 2020 | 6 | 0.350 |
Why?
|
Histological Techniques | 1 | 2009 | 5 | 0.340 |
Why?
|
Osteoarthritis, Hip | 1 | 2009 | 15 | 0.340 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 27 | 0.340 |
Why?
|
Tumor Burden | 1 | 2009 | 60 | 0.340 |
Why?
|
Cytological Techniques | 1 | 2009 | 19 | 0.340 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2009 | 32 | 0.340 |
Why?
|
Systems Integration | 1 | 2007 | 8 | 0.320 |
Why?
|
Medical Records Systems, Computerized | 1 | 2007 | 21 | 0.320 |
Why?
|
Adult | 10 | 2023 | 8420 | 0.310 |
Why?
|
Meningeal Neoplasms | 1 | 2008 | 46 | 0.310 |
Why?
|
Meningioma | 1 | 2008 | 51 | 0.310 |
Why?
|
ROC Curve | 3 | 2018 | 149 | 0.300 |
Why?
|
Cluster Analysis | 3 | 2014 | 128 | 0.300 |
Why?
|
Medical Informatics | 2 | 2018 | 18 | 0.290 |
Why?
|
Databases as Topic | 3 | 2020 | 24 | 0.290 |
Why?
|
Decision Support Techniques | 1 | 2007 | 104 | 0.280 |
Why?
|
Radiographic Image Enhancement | 2 | 2002 | 30 | 0.270 |
Why?
|
Adipose Tissue | 1 | 2009 | 327 | 0.270 |
Why?
|
Glioma | 2 | 2017 | 133 | 0.270 |
Why?
|
Medical Oncology | 1 | 2006 | 70 | 0.260 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 494 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 31 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2024 | 28 | 0.240 |
Why?
|
Habits | 1 | 2023 | 3 | 0.230 |
Why?
|
Metal Nanoparticles | 1 | 2023 | 14 | 0.230 |
Why?
|
Otolaryngology | 2 | 2020 | 17 | 0.230 |
Why?
|
Otitis Media | 1 | 2023 | 21 | 0.230 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2002 | 6 | 0.220 |
Why?
|
Tomography, Spiral Computed | 1 | 2002 | 18 | 0.220 |
Why?
|
Breast | 1 | 2023 | 53 | 0.220 |
Why?
|
Nanoparticles | 1 | 2023 | 47 | 0.220 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 787 | 0.220 |
Why?
|
Computers | 2 | 2015 | 17 | 0.220 |
Why?
|
Internet | 2 | 2017 | 156 | 0.210 |
Why?
|
Risk | 1 | 2023 | 289 | 0.210 |
Why?
|
Telemedicine | 2 | 2020 | 73 | 0.210 |
Why?
|
Health Personnel | 1 | 2023 | 111 | 0.210 |
Why?
|
Area Under Curve | 2 | 2018 | 85 | 0.210 |
Why?
|
Discriminant Analysis | 3 | 2011 | 18 | 0.210 |
Why?
|
Color | 3 | 2011 | 13 | 0.210 |
Why?
|
Pilot Projects | 2 | 2017 | 469 | 0.210 |
Why?
|
Databases, Factual | 3 | 2018 | 332 | 0.200 |
Why?
|
Middle Aged | 7 | 2018 | 10829 | 0.200 |
Why?
|
Models, Statistical | 2 | 2015 | 163 | 0.200 |
Why?
|
Calcinosis | 1 | 2002 | 143 | 0.200 |
Why?
|
Fourier Analysis | 2 | 2011 | 6 | 0.200 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 546 | 0.190 |
Why?
|
Cell Proliferation | 3 | 2018 | 573 | 0.190 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 401 | 0.190 |
Why?
|
Alcohol Drinking | 1 | 2023 | 244 | 0.190 |
Why?
|
Mice | 6 | 2017 | 2368 | 0.180 |
Why?
|
Face | 1 | 2019 | 25 | 0.180 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 64 | 0.180 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 156 | 0.180 |
Why?
|
Workflow | 1 | 2019 | 20 | 0.180 |
Why?
|
Lymph Nodes | 1 | 2019 | 92 | 0.170 |
Why?
|
Data Compression | 1 | 2018 | 2 | 0.170 |
Why?
|
Gene Expression | 2 | 2017 | 332 | 0.170 |
Why?
|
Software Design | 2 | 2009 | 5 | 0.170 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 28 | 0.160 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2009 | 33 | 0.160 |
Why?
|
Aged | 5 | 2017 | 9487 | 0.160 |
Why?
|
Molecular Imaging | 1 | 2018 | 22 | 0.160 |
Why?
|
Computer Communication Networks | 2 | 2007 | 5 | 0.160 |
Why?
|
Database Management Systems | 2 | 2007 | 11 | 0.160 |
Why?
|
Isoindoles | 1 | 2017 | 6 | 0.160 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2017 | 8 | 0.160 |
Why?
|
Automation | 2 | 2009 | 30 | 0.150 |
Why?
|
Dacarbazine | 1 | 2017 | 29 | 0.150 |
Why?
|
Automation, Laboratory | 1 | 2017 | 3 | 0.150 |
Why?
|
Benzamides | 1 | 2017 | 54 | 0.150 |
Why?
|
Entropy | 1 | 2017 | 8 | 0.150 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 81 | 0.150 |
Why?
|
Animals | 8 | 2017 | 7297 | 0.150 |
Why?
|
Proteomics | 1 | 2017 | 92 | 0.140 |
Why?
|
Ultrasonography | 1 | 2018 | 345 | 0.140 |
Why?
|
Prostate | 1 | 2016 | 68 | 0.140 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 493 | 0.130 |
Why?
|
Tuberculosis | 1 | 2015 | 14 | 0.130 |
Why?
|
Feasibility Studies | 3 | 2020 | 263 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 69 | 0.130 |
Why?
|
Cytodiagnosis | 1 | 2014 | 16 | 0.130 |
Why?
|
Photography | 1 | 2015 | 33 | 0.130 |
Why?
|
Probability | 1 | 2015 | 150 | 0.130 |
Why?
|
Neutrophils | 1 | 2015 | 102 | 0.130 |
Why?
|
Models, Theoretical | 1 | 2015 | 126 | 0.120 |
Why?
|
Hematoxylin | 1 | 2013 | 3 | 0.120 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2013 | 4 | 0.120 |
Why?
|
Cell Count | 1 | 2013 | 50 | 0.120 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 30 | 0.120 |
Why?
|
Statistics as Topic | 1 | 2013 | 106 | 0.120 |
Why?
|
Adolescent | 3 | 2017 | 3254 | 0.120 |
Why?
|
Child, Preschool | 2 | 2017 | 1167 | 0.110 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 111 | 0.110 |
Why?
|
Radiation Dosage | 1 | 2013 | 72 | 0.110 |
Why?
|
Immunotherapy | 1 | 2013 | 69 | 0.110 |
Why?
|
Natural Language Processing | 1 | 2012 | 2 | 0.110 |
Why?
|
Flavonoids | 1 | 2012 | 18 | 0.110 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 103 | 0.110 |
Why?
|
Cell Line, Tumor | 4 | 2017 | 680 | 0.110 |
Why?
|
Autophagy | 1 | 2012 | 53 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 89 | 0.100 |
Why?
|
Piperidines | 1 | 2012 | 125 | 0.100 |
Why?
|
Cell Shape | 1 | 2011 | 26 | 0.100 |
Why?
|
Cell Size | 1 | 2011 | 32 | 0.100 |
Why?
|
Apoptosis | 1 | 2013 | 337 | 0.100 |
Why?
|
Hyperplasia | 1 | 2011 | 38 | 0.100 |
Why?
|
Cells | 1 | 2010 | 4 | 0.100 |
Why?
|
Lymphoma, T-Cell | 1 | 2010 | 5 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2009 | 10 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2009 | 20 | 0.090 |
Why?
|
Europe | 1 | 2009 | 77 | 0.090 |
Why?
|
Infant | 1 | 2013 | 969 | 0.090 |
Why?
|
Pattern Recognition, Physiological | 1 | 2009 | 3 | 0.090 |
Why?
|
Coloring Agents | 1 | 2009 | 30 | 0.090 |
Why?
|
Protein Array Analysis | 1 | 2009 | 16 | 0.090 |
Why?
|
Fibroblasts | 1 | 2009 | 103 | 0.090 |
Why?
|
Respiratory System | 1 | 2009 | 12 | 0.090 |
Why?
|
Biomedical Engineering | 1 | 2009 | 23 | 0.090 |
Why?
|
Likelihood Functions | 1 | 2009 | 39 | 0.090 |
Why?
|
Mitosis | 1 | 2009 | 22 | 0.090 |
Why?
|
Thigh | 1 | 2009 | 39 | 0.090 |
Why?
|
Cytoplasm | 1 | 2009 | 30 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2009 | 60 | 0.080 |
Why?
|
Cell Death | 1 | 2009 | 71 | 0.080 |
Why?
|
Radiography | 1 | 2010 | 353 | 0.080 |
Why?
|
Contrast Media | 1 | 2009 | 123 | 0.080 |
Why?
|
Aged, 80 and over | 2 | 2009 | 3717 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2013 | 3099 | 0.080 |
Why?
|
Retrospective Studies | 3 | 2018 | 3111 | 0.080 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2007 | 1 | 0.080 |
Why?
|
Data Display | 1 | 2007 | 2 | 0.080 |
Why?
|
Computer Security | 1 | 2007 | 5 | 0.080 |
Why?
|
Biomedical Research | 1 | 2009 | 153 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2007 | 43 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2009 | 637 | 0.070 |
Why?
|
Computational Biology | 1 | 2007 | 86 | 0.070 |
Why?
|
Signal Transduction | 3 | 2017 | 666 | 0.070 |
Why?
|
Equipment Design | 1 | 2006 | 167 | 0.070 |
Why?
|
Inflammation | 1 | 2009 | 507 | 0.070 |
Why?
|
Interferon-gamma | 2 | 2015 | 51 | 0.060 |
Why?
|
United States | 2 | 2009 | 3630 | 0.060 |
Why?
|
Static Electricity | 1 | 2023 | 11 | 0.060 |
Why?
|
Gold | 1 | 2023 | 15 | 0.060 |
Why?
|
Nanotechnology | 1 | 2023 | 15 | 0.060 |
Why?
|
False Positive Reactions | 1 | 2002 | 25 | 0.060 |
Why?
|
Quality Control | 1 | 2002 | 38 | 0.060 |
Why?
|
Echoencephalography | 1 | 2022 | 4 | 0.060 |
Why?
|
Temporal Bone | 1 | 2022 | 17 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2017 | 980 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 196 | 0.050 |
Why?
|
Mammography | 1 | 2002 | 37 | 0.050 |
Why?
|
DNA | 1 | 2023 | 204 | 0.050 |
Why?
|
Logistic Models | 1 | 2023 | 727 | 0.050 |
Why?
|
Video Recording | 1 | 2020 | 52 | 0.050 |
Why?
|
China | 1 | 2018 | 44 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2002 | 384 | 0.040 |
Why?
|
World Health Organization | 1 | 2018 | 15 | 0.040 |
Why?
|
Kidney | 1 | 2022 | 485 | 0.040 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2017 | 1 | 0.040 |
Why?
|
Acoustic Impedance Tests | 1 | 2017 | 3 | 0.040 |
Why?
|
Ear Canal | 1 | 2017 | 4 | 0.040 |
Why?
|
Zebrafish | 1 | 2017 | 24 | 0.040 |
Why?
|
Otitis Media with Effusion | 1 | 2017 | 10 | 0.040 |
Why?
|
Drug Synergism | 1 | 2017 | 67 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 36 | 0.040 |
Why?
|
Protein Transport | 1 | 2017 | 74 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2017 | 42 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 113 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 69 | 0.040 |
Why?
|
RNA Interference | 1 | 2017 | 76 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 90 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 273 | 0.040 |
Why?
|
Cell Movement | 1 | 2017 | 161 | 0.040 |
Why?
|
Chemokine CXCL5 | 1 | 2015 | 3 | 0.030 |
Why?
|
Chemokine CXCL2 | 1 | 2015 | 9 | 0.030 |
Why?
|
Chemokine CXCL1 | 1 | 2015 | 16 | 0.030 |
Why?
|
Chemokines | 1 | 2015 | 35 | 0.030 |
Why?
|
Incidence | 1 | 2018 | 1119 | 0.030 |
Why?
|
Necrosis | 1 | 2015 | 53 | 0.030 |
Why?
|
Survival Rate | 1 | 2017 | 795 | 0.030 |
Why?
|
Disease Progression | 1 | 2017 | 572 | 0.030 |
Why?
|
Cohort Studies | 1 | 2018 | 1687 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 337 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 200 | 0.030 |
Why?
|
Cytokines | 1 | 2015 | 243 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2013 | 4 | 0.030 |
Why?
|
Diffusion | 1 | 2013 | 12 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 1305 | 0.030 |
Why?
|
Cell Communication | 1 | 2013 | 30 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 711 | 0.030 |
Why?
|
Starvation | 1 | 2012 | 2 | 0.030 |
Why?
|
Vidarabine | 1 | 2012 | 3 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2012 | 10 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 23 | 0.030 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2012 | 17 | 0.030 |
Why?
|
Cell Survival | 1 | 2013 | 272 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 158 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 77 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 836 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2012 | 165 | 0.030 |
Why?
|
Models, Biological | 1 | 2013 | 373 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2010 | 4 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2010 | 18 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2010 | 18 | 0.020 |
Why?
|
Young Adult | 1 | 2017 | 2402 | 0.020 |
Why?
|
Drug Design | 1 | 2010 | 44 | 0.020 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2009 | 1 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 48 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2011 | 95 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2010 | 48 | 0.020 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2009 | 25 | 0.020 |
Why?
|
Gene Deletion | 1 | 2009 | 64 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 57 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2009 | 64 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2009 | 249 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 249 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2009 | 226 | 0.020 |
Why?
|
Computer Graphics | 1 | 2007 | 11 | 0.020 |
Why?
|
Radiology | 1 | 2007 | 37 | 0.020 |
Why?
|